What makes Neurocrine Biosciences, Inc. (NBIX) Stock unique?
Wells Fargo raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock from “an Equal weight” to “an Overweight”. The rating was released on April 24, 2024, according to finviz. The research report from Deutsche Bank has initiated the stock to Buy, with a price target set at $136. The stock was resumed by […]
Neurocrine Biosciences, Inc. (NBIX) Stock Still Strong Despite Competition
Wells Fargo raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock from “an Equal weight” to “an Overweight”. The rating was released on Apr-25-24, according to finviz. The research report from Deutsche Bank has initiated the stock to Buy, with a price target set at $136. The stock was resumed by Cantor Fitzgerald, […]
Neurocrine Biosciences, Inc. (NBIX) Stock: Pessimism is a stepping stone to opportunity
Citigroup raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock to “a Neutral”. The rating was released on December 13, 2023, according to finviz. The research report from Cantor Fitzgerald has resumed the stock to Overweight, with a price target set at $140. The stock was reiterated by Mizuho, who disclosed in a […]
Neurocrine Biosciences, Inc. (NBIX) Stock deserves your attention
Citigroup raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock to “a Neutral”. The rating was released on December 13, 2023, according to finviz. The research report from Cantor Fitzgerald has resumed the stock to Overweight, with a price target set at $140. The stock was reiterated by Mizuho, who disclosed in a […]
Why Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock rose 23.08% in Last Six Months?
Citigroup raised the price target for the Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock to “a Neutral”. The rating was released on December 13, 2023, according to finviz. The research report from Cantor Fitzgerald has resumed the stock to Overweight, with a price target set at $140. The stock was reiterated by Mizuho, who disclosed in a […]
